Search Results

There are 987 results for: content related to: Differential effects of selective and non-selective muscarinic antagonists on gastrointestinal transit and bowel function in healthy women

  1. Which anticholinergic drug for overactive bladder symptoms in adults

    Intervention Review

    The Cochrane Library

    Priya Madhuvrata, June D Cody, Gaye Ellis, G Peter Herbison and E. Jean C Hay-Smith

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD005429.pub2

  2. You have free access to this content
    The cost-effectiveness of solifenacin vs fesoterodine, oxybutynin immediate-release, propiverine, tolterodine extended-release and tolterodine immediate-release in the treatment of patients with overactive bladder in the UK National Health Service

    BJU International

    Volume 106, Issue 4, August 2010, Pages: 506–514, Linda Cardozo, Andrew Thorpe, Juliet Warner and Manpreet Sidhu

    Version of Record online : 3 FEB 2010, DOI: 10.1111/j.1464-410X.2009.09160.x

  3. You have free access to this content
    Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms

    BJU International

    Volume 109, Issue 12, June 2012, Pages: 1831–1840, Steven A. Kaplan, Claus G. Roehrborn, Jason Gong, Franklin Sun and Zhonghong Guan

    Version of Record online : 3 OCT 2011, DOI: 10.1111/j.1464-410X.2011.10624.x

  4. You have free access to this content
    Superior efficacy of fesoterodine over tolterodine extended release with rapid onset: a prospective, head-to-head, placebo-controlled trial

    BJU International

    Volume 107, Issue 9, May 2011, Pages: 1432–1440, Steven A. Kaplan, Tim Schneider, Jenelle E. Foote, Zhonghong Guan, Martin Carlsson and Jason Gong

    Version of Record online : 21 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09640.x

  5. You have free access to this content
    Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo

    BJU International

    Volume 101, Issue 8, April 2008, Pages: 1036–1042, Peter Ney, Raj Kumar Pandita, Donald T. Newgreen, Alexander Breidenbach, Thomas Stöhr and Karl-Erik Andersson

    Version of Record online : 15 FEB 2008, DOI: 10.1111/j.1464-410X.2007.07358.x

  6. You have free access to this content
    Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial

    BJU International

    Volume 114, Issue 3, September 2014, Pages: 418–426, Christopher Chapple, Tim Schneider, François Haab, Franklin Sun, Laurence Whelan, David Scholfield, Erika Dragon and Erin Mangan

    Version of Record online : 1 JUL 2014, DOI: 10.1111/bju.12678

  7. Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature

    International Journal of Clinical Practice

    Volume 65, Issue 5, May 2011, Pages: 567–585, C. C. Sexton, S. M. Notte, C. Maroulis, R. R. Dmochowski, L. Cardozo, D. Subramanian and K. S. Coyne

    Version of Record online : 13 APR 2011, DOI: 10.1111/j.1742-1241.2010.02626.x

  8. You have free access to this content
    Patient-optimized doses of fesoterodine improve bladder symptoms in an open-label, flexible-dose study

    BJU International

    Volume 107, Issue 4, February 2011, Pages: 603–611, Jean-Jacques Wyndaele, Evan R. Goldfischer, Jon D. Morrow, Jason Gong, Li-Jung Tseng and Myung-Soo Choo

    Version of Record online : 22 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09587.x

  9. Factors associated with dose escalation of fesoterodine for treatment of overactive bladder in people >65 years of age: A post hoc analysis of data from the SOFIA study

    Neurourology and Urodynamics

    Volume 34, Issue 5, June 2015, Pages: 438–443, Adrian Wagg, Amanda Darekar, Daniel Arumi, Vik Khullar and Matthias Oelke

    Version of Record online : 3 APR 2014, DOI: 10.1002/nau.22603

  10. You have free access to this content
    Fesoterodine in patients with overactive bladder syndrome: can the severity of baseline urgency urinary incontinence predict dosing requirement?

    BJU International

    Volume 106, Issue 6, September 2010, Pages: 816–821, Linda Cardozo, Vik Khullar, Joseph T. Wang, Zhonghong Guan and Peter K. Sand

    Version of Record online : 26 AUG 2010, DOI: 10.1111/j.1464-410X.2010.09202.x

  11. Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review

    International Journal of Clinical Practice

    Volume 65, Issue 4, April 2011, Pages: 487–507, S. A. Kaplan, C. G. Roehrborn, P. Abrams, C. R. Chapple, T. Bavendam and Z. Guan

    Version of Record online : 7 JAN 2011, DOI: 10.1111/j.1742-1241.2010.02611.x

  12. You have free access to this content
    Sustained improvement in patient-reported outcomes during long-term fesoterodine treatment for overactive bladder symptoms: pooled analysis of two open-label extension studies

    BJU International

    Volume 110, Issue 3, August 2012, Pages: 392–400, Con J. Kelleher, Roger R. Dmochowski, Sandra Berriman, Zoe S. Kopp and Martin Carlsson

    Version of Record online : 30 NOV 2011, DOI: 10.1111/j.1464-410X.2011.10774.x

  13. Abstracts

    Neurourology and Urodynamics

    Volume 35, Issue S4, August 2016, Pages: S1–S471,

    Version of Record online : 5 JUL 2016, DOI: 10.1002/nau.23074

  14. You have free access to this content
    Early onset of fesoterodine efficacy in subjects with overactive bladder

    BJU International

    Volume 107, Issue 4, February 2011, Pages: 598–602, Howard B. Goldman, Jon D. Morrow, Jason Gong, Li-Jung Tseng and Tim Schneider

    Version of Record online : 24 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09586.x

  15. Effects of voluntary dose escalation in a placebo-controlled, flexible-dose trial of fesoterodine in subjects with overactive bladder

    Neurourology and Urodynamics

    Volume 30, Issue 8, November 2011, Pages: 1480–1485, David Staskin, Vik Khullar, Martin C. Michel, Jon D. Morrow, Franklin Sun, Zhonghong Guan and Roger Dmochowski

    Version of Record online : 10 MAY 2011, DOI: 10.1002/nau.21099

  16. Urinary Incontinence

    Dewhurst's Textbook of Obstetrics & Gynaecology, Eighth Edition

    Dudley Robinson, Linda Cardozo, Pages: 635–692, 2012

    Published Online : 5 JAN 2012, DOI: 10.1002/9781119979449.ch51

  17. Abstracts

    Neurourology and Urodynamics

    Volume 34, Issue S3, August 2015, Pages: S1–S461,

    Version of Record online : 5 JUL 2015, DOI: 10.1002/nau.22830

  18. Adherence, persistence and switch rates for anticholinergic drugs used for overactive bladder in women: data from the Norwegian Prescription Database

    Acta Obstetricia et Gynecologica Scandinavica

    Volume 92, Issue 10, October 2013, Pages: 1208–1215, Siri A. Mauseth, Svetlana Skurtveit and Olav Spigset

    Version of Record online : 11 JUL 2013, DOI: 10.1111/aogs.12196

  19. You have full text access to this OnlineOpen article
    Flexible dosing with fesoterodine 4 and 8 mg: a systematic review of data from clinical trials

    International Journal of Clinical Practice

    Volume 68, Issue 7, July 2014, Pages: 830–840, J. J. Wyndaele, T. Schneider, S. MacDiarmid, D. Scholfield and D. Arumi

    Version of Record online : 22 APR 2014, DOI: 10.1111/ijcp.12425

  20. Efficacy, Safety and Tolerability of Fesoterodine in Asian Patients with Overactive Bladder

    LUTS: Lower Urinary Tract Symptoms

    Volume 3, Issue 1, April 2011, Pages: 43–50, Osamu YAMAGUCHI, Osamu NISHIZAWA, Masayuki TAKEDA, Masaki YOSHIDA, Myung-Soo CHOO, Jeong GU LEE, Alex TONG-LONG LIN, Ho-Hsiung LIN, Wai-chun ANDREW YIP, Hitoshi ISOWA and Shintaro HIRO

    Version of Record online : 7 APR 2011, DOI: 10.1111/j.1757-5672.2011.00091.x